Hydroxyzine Hydrochloride Tablet, Film Coated
Product Images NDC 60760-990

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Hydroxyzine Hydrochloride (NDC 60760-990). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by St. Mary's Medical Park Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (9ca46d47 3a27 47d8 B2ca A2f5719a8042 01)

Structural Formula (9ca46d47 3a27 47d8 B2ca A2f5719a8042 01)
Chemical structure of hydroxyzine hydrochloride showing its molecular formula arrangement including aromatic rings, nitrogen atoms, and a hydroxyl group.*
FDA Label Image

990-30 (Hydroxyzine 60760 990 30)

990-30 (Hydroxyzine 60760 990 30)
Label for Hydroxyzine Hydrochloride Tablets, USP 25 mg, film-coated oral tablets packaged in a quantity of 30. The label shows the product name, strength, dosage form, quantity, NDC 60760-990-30, and indicates St. Mary's Medical Park Pharmacy as the packager. Manufacturing is noted as by Graviti Pharmaceuticals Pvt. Ltd., Telangana, India. Additional directions state 'Use as directed' and storage instructions specify controlled room temperature 15°-30°C (59°-86°F).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.